Table 3.
Indirect effects from mediation analyses (0 = abstinent, 1 = relapsed)
| 95% CI† | ||||
|---|---|---|---|---|
| Path | B | SE | Upper | Lower |
| P ➔ DM➔ SR | −0.47 | 0.36 | −1.31 | −0.06 |
| P ➔ PS➔SR | −0.26 | 0.28 | −1.00 | 0.06 |
| P ➔ A➔ SR | −0.16 | 0.18 | −0.63 | 0.11 |
| P ➔ SE ➔ SR1 | 0.01 | 0.26 | −0.53 | 0.56 |
| P ➔ SE ➔ SR2 | −0.01 | 0.28 | −0.52 | 0.57 |
| P ➔ SE ➔ SR3 | 0.06 | 0.22 | −0.36 | 0.55 |
| P ➔PS ➔ SE ➔ SR | 0.22 | 0.17 | 0.03 | 0.65 |
| P ➔ DM ➔ SE ➔ SR | 0.15 | 0.13 | 0.00 | 0.47 |
| P ➔ A ➔ SE ➔ SR | 0.06 | 0.06 | −0.04 | 0.21 |
P = pain (How much bodily pain have you had during the past four weeks); DM = depressed mood (I feel depressed); PS = stress (I feel stressed); A = anxiety (I feel anxious), SE, mood-related smoking outcome expectancy (I am confident that smoking would improve my mood); SR = smoking relapse (based on biochemically confirmed 7-day point-prevalence smoking abstinence).
Bias corrected bootstrapped confidence intervals (10000 bootstrap samples).
This indirect pathway is based on the model that regressed smoking relapse on pain, stress, and mood-related smoking outcome expectancy.
This indirect pathway is based on the model that regressed smoking relapse on pain, depressed mood, and mood-related smoking outcome expectancy.
This indirect pathway is based on the model that regressed smoking relapse on pain, anxiety, and mood-related smoking outcome expectancy.
Note: Bolded text indicates a significant indirect effect.